- Corporate Officers - S
- Stockwell Lynn
Insider Trading History of Stockwell Lynn
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stockwell Lynn since 2024.
This trader's CIK number is 1927032.
At the time of last reporting, Stockwell Lynn was the CEO and Exe. Chair of Board of Drugs Made In America Acquisition Ii Corp.. (stock ticker symbol DMII).
Also see all insider trading activities at Drugs Made In America Acquisition Ii Corp..
Note that in the past
Stockwell Lynn also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Bright Green Corp (BGXX) by Stockwell Lynn
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | BGXX | 0 | $0 | 1,000,000 | $360,000 | 0 | $0 |
Yearly summary of insider trading at Drugs Made In America Acquisition Corp. (DMAA) by Stockwell Lynn
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | DMAA | 460,000 | $0 | 5,698,363 | $0 | 0 | $0 |
Yearly summary of insider trading at Drugs Made In America Acquisition Ii Corp. (DMII) by Stockwell Lynn
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | DMII | 700,000 | $0 | 7,966,667 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Stockwell Lynn:
1. Bright Green Corp (BGXX)
2. Drugs Made In America Acquisition Corp. (DMAA)
3. Drugs Made In America Acquisition Ii Corp. (DMII)
Table 1. Insider trading of Bright Green Corp (BGXX) by Stockwell Lynn
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-05 | BGXX | Sale | 1,000,000 | .36 | 360,000 |
Table 2. Insider trading of Drugs Made In America Acquisition Corp. (DMAA) by Stockwell Lynn
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-02-18 | DMAA | Buy | 30,000 | .00 | 0 |
| 2025-02-18 | DMAA | Buy | 30,000 | .00 | 0 |
| 2025-01-29 | DMAA | Sale | 5,698,363 | .00 | 0 |
| 2025-01-29 | DMAA | Buy | 400,000 | .00 | 0 |
Table 3. Insider trading of Drugs Made In America Acquisition Ii Corp. (DMII) by Stockwell Lynn
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-09-26 | DMII | Sale | 7,966,667 | .00 | 0 |
| 2025-09-26 | DMII | Buy | 700,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Stockwell Lynn
(CEO and Exe. Chair of Board of Drugs Made In America Acquisition Ii Corp. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.